Assessment and treatment of suicide risk in bipolar disorders

Expert Review of Neurotherapeutics

Volumn 9, Issue 1, 2009, Pages 109-136

  Pompili, Maurizio ^a,b   Rihmer, Zoltán ^c   Innamorati, Marco ^d   Lester, David ^e   Girardi, Paolo ^a   Tatarelli, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MCLEAN HOSPITAL   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Universita' Europea Roma   (Italy)

^e RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

Author keywords

Bipolar disorder; Risk factors; Suicide; Therapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; VALPROIC ACID;

ABUSE; ALCOHOL ABUSE; ALCOHOLISM; BIPOLAR DISORDER; BIPOLAR II DISORDER; CAUCASIAN; DEPRESSION; DYSPHORIA; EPILEPSY; FAMILY HISTORY; HOPELESSNESS; HUMAN; IMPULSIVENESS; MANIA; MONOTHERAPY; MOOD DISORDER; NEUROIMAGING; PATIENT COMPLIANCE; PERSONALITY; PSYCHOEDUCATION; REVIEW; RISK; SEXUAL ABUSE; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; TEMPERAMENT; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

BIPOLAR DISORDER; HUMANS; LITHIUM COMPOUNDS; RISK FACTORS; SUICIDE;

EID: 58149280388     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.9.1.109     Document Type: Review

References (307)

1. Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 17(7), 491-511 (2003).
2. Rihmer Z. Prediction and prevention of suicide in bipolar disorders. Clin. Neuropsychiatry 2(1), 48-54 (2005).
3. Baldessarini RJ, Tondo L, Davis P et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 8(5 Pt 2), 625-639 (2006).
4. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 359(9302), 241-247 (2002).
5. Rihmer Z, Angst J. Epidemiology of bipolar disorder. In: Handbook of Bipolar Disorder. Kasper S, Hirscfeld RMA (Eds). Taylor and Francis, NY, USA 21-35 (2005).
6. Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Annu. Rev. Clin. Psychol. 2, 199-235 (2006).
7. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 617-627 (2005).
8. Regeer EJ, ten Have M, Rosso ML et al. Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr. Scand. 110(5), 374-382 (2004).
9. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 293(20), 2487-2495 (2005).
10. Leibenluft E. Issues in the treatment of women with bipolar illness. J. Clin. Psychiatry 58(Suppl. 15), 5-11 (1997).
11. Schneck CD, Miklowitz DJ, Calabrese JR et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am. J. Psychiatry 161(10), 1902-1908 (2004).
12. Coryell W, Solomon D, Turvey C et al. The long-term course of rapid-cycling bipolar disorder. Arch. Gen. Psychiatry 60(9), 914-920 (2003).
13. Suominen K, Mantere O, Valtonen H et al. Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking. Bipolar Disord. 9(7), 698-705 (2007).
14. Wickramaratne PJ, Weissman MM, Leaf PJ, Holford TR. Age, period and cohort effects on the risk of major depression: results from five United States communities. J. Clin. Epidemiol. 42(4), 333-343 (1989).
15. Rice J, Reich T, Andreasen NC et al. The familial transmission of bipolar illness. Arch. Gen. Psychiatry 44(5), 441-447 (1987).
16. Ryan ND, Williamson DE, Iyengar S et al. A secular increase in child and adolescent onset affective disorder. J. Am. Acad. Child. Adolesc. Psychiatry 31(4), 600-605 (1992).
17. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J. Clin. Psychopharmacol. 16(2 Suppl. 1), 4S-14S (1996).
18. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord. 73(1-2), 123-131 (2003).
19. Faravelli C, Rosi S, Alessandra Scarpato M et al. Threshold and subthreshold bipolar disorders in the Sesto Fiorentino Study. J. Affect. Disord. 94(1-3), 111-119 (2006).
20. Pompili M, Girardi P, Tatarelli R, Lester D. Subthreshold bipolar traits and suicide risk among undergraduates. Psychol. Rep. 98(2), 417-418 (2006).
21. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 5(6), 456-463 (2003).
22. Goodwin FK, Jamison KR. Manic-Depressive Illness. Oxford University Press, New York, USA (2007).
23. Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch. Suicide Res. 9(3), 279-300 (2005).
24. Arvilommi P, Suominen KS, Mantere OK et al. Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders. J. Clin. Psychiatry 68(1), 102-110 (2007).
25. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J. Clin. Psychopharmacol. 16(2 Suppl. 1), 24S-31S (1996).
26. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am. J. Psychiatry 152(11), 1635-1640 (1995).
27. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 59(6), 530-537 (2002).
28. Keller MB, Lavori PW, Coryell W, Endicott J, Mueller TI. Bipolar I: a five-year prospective follow-up. J. Nerv. Ment. Dis. 181(4), 238-245 (1993).
29. Post RM, Denicoff KD, Leverich GS et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J. Clin. Psychiatry 64(6), 680-690 (2003).
30. Jamison KR. Suicide and bipolar disorder. J. Clin. Psychiatry 61 (Suppl. 9), 47-51 (2000).
31. Tondo L, Baldessarini RJ. Suicidal risk in bipolar disorder. Clin. Neuropsychiatry 2(1), 55-65 (2005).
32. Baldessarini RJ, Pompili M, Tondo L. Bipolar disorder. In: American Psychiatric Textbook of Suicide Assessment and Management. Simon RI, Hales RE (Eds). American Psychiatric Publishing, DC, USA, 277-299 (2006).
33. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry 170, 205-228 (1997).
34. Ahrens B, Muller-Oerlinghausen B, Schou M et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J. Affect. Disord. 33(2), 67-75 (1995).
35. Sharma R, Markar HR. Mortality in affective disorder. J. Affect. Disord. 31(2), 91-96 (1994).
36. Hawton K, Arensman E, Wasserman D et al. Relation between attempted suicide and suicide rates among young people in Europe. J. Epidemiol. Community Health 52(3), 191-194 (1998).
37. Guze SB, Robins E. Suicide and primary affective disorders. Br. J. Psychiatry 117(539), 437-438 (1970).
38. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br. J. Psychiatry 172, 35-37 (1998).
39. Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML. Lifetime suicide risk in major depression: sex and age determinants. J. Affect. Disord. 55(2-3), 171-178 (1999).
40. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry 157(12), 1925-1932 (2000).
41. O'Leary D, Paykel E, Todd C, Vardulaki K. Suicide in primary affective disorders revisited: a systematic review by treatment era. J. Clin. Psychiatry 62(10), 804-811 (2001).
42. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch. Gen. Psychiatry 56(7), 617-626 (1999).
43. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58(9), 844-850 (2001).
44. Akiskal H. Targeting suicide prevention to modifiable risk factors: has bipolar II been overlooked? Acta Psychiatr. Scand. 116(6), 395-402 (2007).
45. Tondo L, Lepri B, Baldessarini RJ. Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr. Scand. 116(6), 419-428 (2007).
46. Akiskal HS, Maser JD, Zeller PJ et al. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry 52(2), 114-123 (1995).
47. Goldberg JF, Singer TM, Garno JL. Suicidality and substance abuse in affective disorders. J. Clin. Psychiatry 62 (Suppl. 25), 35-43 (2001).
48. Benazzi F, Akiskal HS. Clinical and factor-analytic validation of depressive mixed states: a report from the Ravenna-San Diego collaboration. Curr. Opin. Psychiatry 16(Suppl. 2), 71-78 (2003).
49. Arato M, Demeter E, Rihmer Z, Somogyi E. Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr. Scand. 77(4), 454-456 (1988).
50. Rihmer Z, Barsi J, Arato M, Demeter E. Suicide in subtypes of primary major depression. J. Affect. Disord. 18(3), 221-225 (1990).
51. Rihmer Z, Rutz W, Pihlgren H. Depression and suicide on Gotland. An intensive study of all suicides before and after a depression-training programme for general practitioners. J. Affect. Disord. 35(4), 147-152 (1995).
52. Balazs J, Lecrubier Y, Csiszer N, Kosztak J, Bitter I. Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. J. Affect. Disord. 76(1-3), 113-119 (2003).
53. Raja M, Azzoni A. Suicide attempts: differences between unipolar and bipolar patients and among groups with different lethality risk. J. Affect. Disord. 82(3), 437-442 (2004).
54. Rihmer A, Rihmer Z, Jekkel E et al. Psychiatric characteristics of 100 nonviolent suicide attempters in Hungary. Int. J. Psychiatry Clin. Pract. 10(1), 69-72 (2006).
55. Perlis RH, Miyahara S, Marangell LB et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol. Psychiatry 55(9), 875-881 (2004).
56. Lopez P, Mosquera F, de Leon J et al. Suicide attempts in bipolar patients. J. Clin. Psychiatry 62(12), 963-966 (2001).
57. Leverich GS, Altshuler LL, Frye MA et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J. Clin. Psychiatry 64(5), 506-515 (2003).
58. Fagiolini A, Kupfer DJ, Rucci P et al. Suicide attempts and ideation in patients with bipolar I disorder. J. Clin. Psychiatry 65(4), 509-514 (2004).
59. Slama F, Bellivier F, Henry C et al. Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J. Clin. Psychiatry 65(8), 1035-1039 (2004).
60. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J. Clin. Psychiatry 63(11), 985-991 (2002).
61. Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J. Affect. Disord. 82(3), 373-383 (2004).
62. Hantouche EG, Akiskal HS, Lancrenon S et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J. Affect. Disord. 50(2-3), 163-173 (1998).
63. Benazzi F. Mood patterns and classification in bipolar disorder. Curr. Opin. Psychiatry 19(1), 1-8 (2006).
64. Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85(3), 245-258 (2005).
65. Benazzi F. Suicidal ideation and depressive mixed states. Psychother. Psychosom. 74(1), 61-62 (2005).
66. Sato T, Bottlender R, Kleindienst N, Moller HJ. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression. J. Affect. Disord. 84(2-3), 187-196 (2005).
67. Balazs J, Benazzi F, Rihmer Z et al. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91(2-3), 133-138 (2006).
68. Hawton K, van Heeringen K (Eds). The International Handbook of Suicide and Attempted Suicide. John Wiley & Sons, Chichester, UK (2000).
69. Isometsa ET, Henriksson MM, Aro HM, Lonnqvist JK. Suicide in bipolar disorder in Finland. Am. J. Psychiatry 151(7), 1020-1024 (1994).
70. Oquendo MA, Waternaux C, Brodsky B et al. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J. Affect. Disord. 59(2), 107-117 (2000).
71. Bulik CM, Carpenter LL, Kupfer DJ, Frank E. Features associated with suicide attempts in recurrent major depression. J. Affect. Disord. 18(1), 29-37 (1990).
72. Oquendo MA, Galfalvy H, Russo S et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am. J. Psychiatry 161(8), 1433-1441 (2004).
73. Akiskal HS, Benazzi F. Delineating depressive mixed states. Their therapeutic significance. Clin. Approach Bipolar Disord. 2, 41-47 (2003).
74. Maj M, Pirozzi R, Magliano L, Bartoli L. Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome. Am. J. Psychiatry 160(12), 2134-2140 (2003).
75. Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur. Psychiatry 19(2), 85-90 (2004).
76. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol. Psychiatry 39(10), 896-899 (1996).
77. Hawgood J, De Leo D. Anxiety disorders and suicidal behaviour: an update. Curr. Opin. Psychiatry 21(1), 51-64 (2008).
78. Tondo L, Baldessarini RJ, Hennen J et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J. Clin. Psychiatry 60 (Suppl. 2), 63-69 (1999).
79. Szadoczky E, Vitrai J, Rihmer Z, Furedi J. Suicide attempts in the Hungarian adult population: their relation with DIS/DSM-III-R affective and anxiety disorders. Eur. Psychiatry 15(6), 343-347 (2000).
80. McElroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am. J. Psychiatry 158(3), 420-426 (2001).
81. Simon NM, Otto MW, Wisniewski SR et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 161(12), 2222-2229 (2004).
82. Perroud N, Baud P, Preisig M et al. Social phobia is associated with suicide attempt history in bipolar inpatients. Bipolar Disord. 9(7), 713-721 (2007).
83. Rihmer Z, Dome P, Gonda X et al. Cigarette smoking and suicide attempts in psychiatric outpatients in Hungary. Neuropsychopharmacol. Hung. 9(2), 63-67 (2007).
84. Nakagawa A, Grunebaum MF, Sullivan GM et al. Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality? Bipolar Disord. 10(4), 530-538 (2008).
85. Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am. J. Psychiatry 155(5), 638-645 (1998).
86. Rouillon F, Serrurier D, Miller HD, Gerard MJ. Prophylactic efficacy of maprotiline on unipolar depression relapse. J. Clin. Psychiatry 52(10), 423-431 (1991).
87. Valtonen H, Suominen K, Mantere O et al. Suicidal ideation and attempts in bipolar I and II disorders. J. Clin. Psychiatry 66(11), 1456-1462 (2005).
88. Sato T, Bottlender R, Tanabe A, Moller HJ. Cincinnati criteria for mixed mania and suicidality in patients with acute mania. Compr. Psychiatry 45(1), 62-69 (2004).
89. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Krajewski KJ. Suicidality in patients with pure and depressive mania. Am. J. Psychiatry 151(9), 1312-1315 (1994).
90. Strakowski SM, McElroy SL, Keck PE Jr, West SA. Suicidality among patients with mixed and manic bipolar disorder. Am. J. Psychiatry 153(5), 674-676 (1996).
91. Fiedorowicz JG, Leon AC, Keller MB et al. Do risk factors for suicidal behavior differ by affective disorder polarity? Psychol. Med. 1-9 (2008).
92. Conwell Y, Henderson RE. Neuropsychiatry of suicide. In: Neuropsychiatry. Fogel BS, Schiffer RB, Rao SM (Eds). Williams & Wilkins, MD, USA 485-521 (1996).
93. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J. Psychosom. Res. 11(2), 213-218 (1967).
94. Dilsaver SC, Chen YW, Swann AC et al. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res. 73(1-2), 47-56 (1997).
95. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am. J. Psychiatry 160(11 Suppl.), 1-60 (2003).
96. Tondo L, Albert MJ, Baldessarini RJ. Suicide rates in relation to health care access in the United States: an ecological study. J. Clin. Psychiatry 67(4), 517-523 (2006).
97. Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr. Clin. North Am. 22(3), 667-673, ix-x (1999).
98. Jacobs DG (Ed.). The Harvard Medical School Guide to Suicide Assessment and Intervention. Jossey-Bass, CA, USA (1999).
99. Ghaemi SN, Rosenquist KJ, Ko JY et al. Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry 161(1), 163-165 (2004).
100. American Association of Suicidology [AAS]. Official 1998 Statistics. (2000)
101. Tohen M, Angst J. Epidemiology of bipolar disorder. In: Textbook in Psychiatric Epidemiology. Tsuang MT, Tohen M (Eds). John Wiley & Sons, NY, USA 427-444 (2002).
102. Simon GE, Hunkeler E, Fireman B, Lee JY, Savarino J. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord. 9(5), 526-530 (2007).
103. Baethge C, Tondo L, Bratti IM et al. Prophylaxis latency and outcome in bipolar disorders. Can. J. Psychiatry 48(7), 449-457 (2003).
104. Faedda GL, Baldessarini RJ, Suppes T et al. Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv. Rev. Psychiatry 3(4), 171-195 (1995).
105. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 6(4), 305-313 (2004).
106. Hastings DW. Follow-up results in psychiatric illness. Am. J. Psychiatry 114(12), 1057-1066 (1958).
107. Tsuang MT. Suicide in schizophrenics, manics, depressives, and surgical controls. A comparison with general population suicide mortality. Arch. Gen. Psychiatry 35(2), 153-155 (1978).
108. Black DW, Winokur G, Nasrallah A. Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders. Am. J. Psychiatry 145(7), 849-852 (1988).
109. Newman SC, Bland RC. Suicide risk varies by subtype of affective disorder. Acta Psychiatr. Scand. 83(6), 420-426 (1991).
110. Lester D. Suicidal behavior in bipolar and unipolar affective disorders: a meta-analysis. J. Affect. Disord. 27(2), 117-121 (1993).
111. Hoyer EH, Mortensen PB, Olesen AV. Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br. J. Psychiatry 176, 76-82 (2000).
112. Kallner G, Lindelius R, Petterson U, Stockman O, Tham A. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry 33(1), 8-13 (2000).
113. Gladstone GL, Mitchell PB, Parker G et al. Indicators of suicide over 10 years in a specialist mood disorders unit sample. J. Clin. Psychiatry 62(12), 945-951 (2001).
114. Carlson GA, Kotin J, Davenport YB, Adland M. Follow-up of 53 bipolar manic-depressive patients. Br. J. Psychiatry 124(579), 134-139 (1974).
115. Morrison JR. Suicide in a psychiatric practice population. J. Clin. Psychiatry 43(9), 348-352 (1982).
116. Dingman CW, McGlashan TH. Characteristics of patients with serious suicidal intentions who ultimately commit suicide. Hosp. Community Psychiatry 39(3), 295-299 (1988).
117. Koukopoulos A, Reginaldi D, Minnai G et al. The long-term prophylaxis of affective disorders. In: Depression and Mania: From Neurobiology to Treatment. Gessa G, Fratta W, Pani L (Eds). Raven Press, NY, USA 127-147 (1995).
118. Angst J, Sellaro R, Angst F. Long-term outcome and mortality of treated vs. untreated bipolar and depressed patients: a preliminary report. Int. J. Psychiatric Clin. Pract. 2, 115-119 (1998).
119. Bottlender R, Jager M, Strauss A, Moller HJ. Suicidality in bipolar compared to unipolar depressed inpatients. Eur. Arch. Psychiatry Clin. Neurosci. 250(5), 257-261 (2000).
120. Thies-Flechtner K, Muller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29(3), 103-107 (1996).
121. Dunner DL, Gershon ES, Goodwin FK. Heri. factors in the severity of affective illness. Biol. Psychiatry 11(1), 31-42 (1976).
122. Swann AC, Gerard Moeller F, Steinberg JL et al. Manic symptoms and impulsivity during bipolar depressive episodes. Bipolar Disord. 9(3), 206-212 (2007).
123. Baca-Garcia E, Diaz-Sastre C, Basurte E et al. A prospective study of the paradoxical relationship between impulsivity and lethality of suicide attempts. J. Clin. Psychiatry 62(7), 560-564 (2001).
124. Yen CF, Cheng CP, Ko CH et al. Suicidality and its association with insight and neurocognition in taiwanese patients with bipolar I disorder in remission. J. Nerv. Ment. Dis. 196(6), 462-467 (2008).
125. Malloy-Diniz LF, Neves FS, Abrantes SS, Fuentes D, Correa H. Suicide behavior and neuropsychological assessment of type I bipolar patients. J. Affect. Disord. 112(1-3), 231-236 (2009).
126. Klimes-Dougan B, Lee CY, Ronsaville D, Martinez P. Suicidal risk in young adult offspring of mothers with bipolar or major depressive disorder: a longitudinal family risk study. J. Clin. Psychol. 64(4), 531-540 (2008).
127. McIntyre RS, Soczynska JK, Mancini D et al. The relationship between childhood abuse and suicidality in adult bipolar disorder. Violence Vict. 23(3), 361-372 (2008).
128. Isometsa E, Heikkinen M, Henriksson M, Aro H, Lonnqvist J. Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides. J. Affect. Disord. 33(2), 99-106 (1995).
129. Rihmer Z, Belso N, Kiss K. Strategies for suicide prevention. Curr. Opin. Psychiatry 15(1), 83-87 (2002).
130. Carballo JJ, Harkavy-Friedman J, Burke AK et al. Family history of suicidal behavior and early traumatic experiences: additive effect on suicidality and course of bipolar illness? J. Affect. Disord. 109(1-2), 57-63 (2008).
131. Romero S, Colom F, Iosif AM et al. Relevance of family history of suicide in the long-term outcome of bipolar disorders. J. Clin. Psychiatry 68(10), 1517-1521 (2007).
132. Cheng AT, Chen TH, Chen CC, Jenkins R. Psychosocial and psychiatric risk factors for suicide. Case-control psychological autopsy study. Br. J. Psychiatry 177, 360-365 (2000).
133. King EA, Baldwin DS, Sinclair JM et al. The Wessex Recent In-Patient Suicide Study, 1. Case-control study of 234 recently discharged psychiatric patient suicides. Br. J. Psychiatry 178, 531-536 (2001).
134. Suominen K, Isometsa E, Suokas J et al. Completed suicide after a suicide attempt: a 37-year follow-up study. Am. J. Psychiatry 161(3), 562-563 (2004).
135. Gibb SJ, Beautrais AL, Fergusson DM. Mortality and further suicidal behaviour after an index suicide attempt: a 10-year study. Aust. NZ J. Psychiatry 39(1-2), 95-100 (2005).
136. Rihmer A, Rossa A, Rihmer Z, Gonda X, Askiskal KK, Akiskal HS. Affective temperaments, as measured by TEMPS-A, among nonviolent suicide attempters. J. Affect. Disord. (In Press).
137. Grunebaum MF, Ramsay SR, Galfalvy HC et al. Correlates of suicide attempt history in bipolar disorder: a stress-diathesis perspective. Bipolar Disord. 8(5 Pt 2), 551-557 (2006).
138. Tondo L, Lepri B, Baldessarini RJ. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr. Scand. 118(2), 106-115 (2008).
139. Pirkis J, Burgess P. Suicide and recency of health care contacts. A systematic review. Br. J. Psychiatry 173, 462-474 (1998).
140. Andersen UA, Andersen M, Rosholm JU, Gram LF. Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders. Acta Psychiatr. Scand. 104(6), 458-465 (2001).
141. Miller CL, Druss B. Datapoints: suicide and access to care. Psychiatr. Serv. 52(12), 1566 (2001).
142. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am. J. Psychiatry 164(7), 1035-1043 (2007).
143. Perlis RH, Stern TA. Suicide. In: Psychiatry Update and Board Preparation. Stern TA, Herman JB (Eds). McGraw-Hill, NY, USA 409-413 (2000).
144. Kochman FJ, Hantouche EG, Ferrari P et al. Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder. J. Affect. Disord. 85(1-2), 181-189 (2005).
145. Akiskal HS. The temperamental foundations of mood disorders. In: Interpersonal Factors in the Origin and Course of Affective Disorders. Mundt CH (Ed.). Gaskell, London, UK 3-30 (1996).
146. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr. Clin. North Am. 22(3), 517-534, vii (1999).
147. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity. J. Affect. Disord. 73(1-2), 49-57 (2003).
148. Rihmer A, Rózsa S, Rihmer Z et al. Affective temperament-types and suicidal behaviour. Eur. Psychiatry 22(Suppl. 1), s244 (2007).
149. Maser JD, Akiskal HS, Schettler P et al. Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-year prospective study. Suicide Life Threat. Behav. 32(1), 10-32 (2002).
150. Pompili M, Rihmer Z, Akiskal HS et al. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients. Psychopathology 41(5), 313-321 (2008).
151. Taylor WD, Payne ME, Krishnan KR et al. Evidence of white matter tract disruption in MRI hyperintensities. Biol. Psychiatry 50(3), 179-183 (2001).
152. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol. Psychiatry 41(1), 86-106 (1997).
153. Judas M, Rados M, Jovanov-Milosevic N et al. Structural, immunocytochemical, and mr imaging properties of periventricular crossroads of growing cortical pathways in preterm infants. AJNR Am. J. Neuroradiol. 26(10), 2671-2684 (2005).
154. Peterson BS. Brain imaging studies of the anatomical and functional consequences of preterm birth for human brain development. Ann. NY Acad. Sci. 1008, 219-237 (2003).
155. Whitaker AH, Van Rossem R, Feldman JF et al. Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Arch. Gen. Psychiatry 54(9), 847-856 (1997).
156. Pompili M, Ehrlich S, De Pisa E et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 257(8), 494-499 (2007).
157. Pompili M, Innamorati M, Mann JJ et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 32(6), 1501-1507 (2008).
158. Ahearn EP, Jamison KR, Steffens DC et al. MRI correlates of suicide attempt history in unipolar depression. Biol. Psychiatry 50(4), 266-270 (2001).
159. Ehrlich S, Noam GG, Lyoo IK et al. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J. Am. Acad. Child. Adolesc. Psychiatry 43(6), 770-776 (2004).
160. Ehrlich S, Breeze JL, Hesdorffer DC et al. White matter hyperintensities and their association with suicidality in depressed young adults. J. Affect. Disord. 86(2-3), 281-287 (2005).
161. Cade JF. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 2(10), 349-352 (1949).
162. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J. Neurol. Neurosurg. Psychiatry 17(4), 250-260 (1954).
163. Jamison KR. Suicide and bipolar disorders. Ann. NY Acad. Sci. 487, 301-315 (1986).
164. Tondo L, Baldessarini RJ, Hennen J et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J. Clin. Psychiatry 59(8), 405-414 (1998).
165. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry 60(Suppl. 2), 77-84 (1999).
166. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr. Scand. 104(3), 163-172 (2001).
167. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex and carbamazepine. J. Affect. Disord. 103(1-3), 5-11 (2007).
168. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics. J. Affect. Disord. 103(1-3), 23-28 (2007).
169. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants. J. Affect. Disord. 103(1-3), 13-21 (2007).
170. Goodwin FK, Fireman B, Simon GE et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290(11), 1467-1473 (2003).
171. Ahrens B, Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 34(4), 132-136 (2001).
172. Marangell LB, Dennehy EB, Wisniewski SR et al. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J. Clin. Psychiatry 69(6), 916-922 (2008).
173. Rihmer Z, Gonda X, Tondo L. Lithium and suicidal behavior in patients with bipolar disorder. J. Clin. Psychiatry (In Press).
174. Sondergard L, Lopez AG, Andersen PK, Kessing LV. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord. 10(1), 87-94 (2008).
175. Baldessarini RJ, Tondo L, Hennen J. Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. Ann. NY Acad. Sci. 932, 24-38 (2001).
176. Baldessarini RJ, Tarazi FI. Drugs for the treatment of psychiatric disorders. In: Goodman and Gilman's the Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds.). McGraw-Hill Press, NY, USA (2001).
177. Mann JJ, Oquendo M, Underwood MD, Arango V. The neurobiology of suicide risk: a review for the clinician. J. Clin. Psychiatry 60(Suppl. 2), 7-11 (1999).
178. Greil W, Ludwig-Mayerhofer W, Erazo N et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J. Affect. Disord. 43(2), 151-161 (1997).
179. Huxley NA, Parikh SV, Baldessarini RJ. Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv. Rev. Psychiatry 8(3), 126-140 (2000).
180. Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder. Arch. Gen. Psychiatry 57(5), 490-492 (2000).
181. Baldessarini RJ, Tondo L. Antisuicidal effect of lithium treatment in major mood disorders. In: Harvard Medical School Guide to Assessment and Intervention in Suicide. Jacobs, DG (Ed.). Jossey-Bass, CA, USA 355-371 (1999).
182. Muller-Oerlinghausen B, Felber W, Berghofer A, Lauterbach E, Ahrens B. The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch. Suicide Res. 9(3), 307-319 (2005).
183. Henry C, Demotes-Mainard J. SSRIs, suicide and violent behavior: is there a need for a better definition of the depressive state? Curr. Drug Saf. 1, 59-62 (2006).
184. Amsterdam JD, Brunswick DJ. Antidepressant monotherapy for bipolar type II major depression. Bipolar Disord. 5(6), 388-395 (2003).
185. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: antidepressant and antianxiety agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, Gilman AG (Eds). McGraw-Hill, NY, USA (2006).
186. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J. Affect. Disord. 84(2-3), 251-257 (2005).
187. Inoue T, Nakagawa S, Kitaichi Y et al. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity. J. Affect. Disord. 95(1-3), 61-67 (2006).
188. O'Donovan C, Garnham JS, Hajek T, Alda M. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. J. Affect. Disord. 107(1-3), 293-298 (2008).
189. Baldessarini RJ, Pompili M, Tondo L et al. Antidepressants and suicidal behavior: are we hurting or helping? Clin. Neuropsychiatry 2(1), 73-75 (2005).
190. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23(1), 68-73 (1987).
191. Harada T, Sakamoto K, Ishigooka J. Incidence and predictors of activation syndrome induced by antidepressants. Depress. Anxiety DOI: 10.1002/da.20438 (2008) (Epub ahead of print).
192. Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J. Clin. Psychiatry 63(9), 791-795 (2002).
193. Ali S, Milev R. Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature. Can. J. Psychiatry 48(4), 258-264 (2003).
194. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant- induced mania in bipolar patients: identification of risk factors. J. Clin. Psychiatry 62(4), 249-255 (2001).
195. Pompili M, Tondo L, Baldessarini RJ. Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin. Neuropsychiatry 2, 66-72 (2005).
196. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24(5), 467-477 (2001).
197. Yatham LN. Diagnosis and management of patients with bipolar II disorder. J. Clin. Psychiatry 66 (Suppl. 1), 13-17 (2005).
198. Moller HJ, Baldwin DS, Goodwin G et al. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur. Arch. Psychiatry Clin. Neurosci. 258(Suppl. 3), 3-23 (2008).
199. Mulder RT, Joyce PR, Frampton CM, Luty SE. Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts. Acta Psychiatr. Scand. 118(2), 116-122 (2008).
200. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry, 60(4), 392-400 (2003).
201. Calabrese JR, Bowden CL, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64(9), 1013-1024 (2003).
202. Dardennes R, Even C, Bange F, Heim A. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. Br. J. Psychiatry 166(3), 378-381 (1995).
203. Denicoff KD, Smith-Jackson EE, Disney ER et al. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J. Clin. Psychiatry 58(11), 470-478 (1997).
204. Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int. Clin. Psychopharmacol. 14(5), 277-281 (1999).
205. Born C, Dittmann S, Post RM, Grunze H. Newer prophylactic agents for bipolar disorder and their influence on suicidality. Arch. Suicide Res. 9(3), 301-306 (2005).
206. Yerevanian BI, Koek RJ, Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J. Affect. Disord. 73(3), 223-228 (2003).
207. Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr. Res. 73(2-3), 139-145 (2005).
208. Meltzer HY, Alphs L, Green AI et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 60(1), 82-91 (2003).
209. Prudic J, Sackeim HA. Electroconvulsive therapy and suicide risk. J. Clin. Psychiatry 60 (Suppl. 2), 104-110 (1999).
210. Consensus conference. Electroconvulsive therapy. JAMA 254(15), 2103-2108 (1985).
211. Weiner RD (Ed.) Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association. American Psychiatric Association, DC, USA (2000).
212. Panksepp J (Ed.) Textbook of Biological Psychiatry. Wiley-Liss, Inc., Hoboken, DE, USA (2004).
213. Lomarev M, Denslow S, Nahas Z et al. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J. Psychiatr. Res. 36(4), 219-227 (2002).
214. Teneback CC, Nahas Z, Speer AM et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J. Neuropsychiatry Clin. Neurosci. 11(4), 426-435 (1999).
215. George MS, Wassermann EM, Williams WA et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6(14), 1853-1856 (1995).
216. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int. J. Neuropsychopharmacol. 5(1), 73-103 (2002).
217. McNamara B, Ray JL, Arthurs OJ, Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol. Med. 31(7), 1141-1146 (2001).
218. Holtzheimer PE 3rd, Russo J, Avery DH. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol. Bull. 35(4), 149-169 (2001).
219. Martin JL, Barbanoj MJ, Schlaepfer TE et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br. J. Psychiatry 182, 480-491 (2003).
220. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J. Psychiatry Neurosci. 30(2), 83-90 (2005).
221. Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr. Scand. 116(3), 165-173 (2007).
222. Kozel FA, George MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J. Psychiatr. Pract. 8(5), 270-275 (2002).
223. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J. Affect. Disord. 88(3), 255-267 (2005).
224. Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J. Clin. Psychiatry 67(12), 1870-1876 (2006).
225. Ebmeier KP, Herrmann LL. TMS - the beginning of the end or the end of the beginning? Psychol. Med. 38(3), 319-321 (2008).
226. Xia G, Gajwani P, Muzina DJ et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 11(1), 119-130 (2008).
227. George MS, Sackeim HA, Rush AJ et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47(4), 287-295 (2000).
228. Van Laere K, Vonck K, Boon P, Versijpt J, Dierckx R. Perfusion SPECT changes after acute and chronic vagus nerve stimulation in relation to prestimulus condition and long-term clinical efficacy. J. Nucl. Med. 43(6), 733-744 (2002).
229. Handforth A, DeGiorgio CM, Schachter SC et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 51(1), 48-55 (1998).
230. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 42(2-3), 203-210 (2000).
231. Harden CL, Pulver MC, Ravdin LD et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 1(2), 93-99 (2000).
232. Rush AJ, George MS, Sackeim HA et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry 47(4), 276-286 (2000).
233. Phurrough S, Salive ME, Lofton B, Schafer J. Decision memo for vagus nerve stimulation for treatment of resistant depression (TRD) (CAG-00313R) (2007).
234. Nahas Z, Marangell LB, Husain MM et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 66(9), 1097-1104 (2005).
235. Sackeim HA, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25(5), 713-728 (2001).
236. Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA 298(3), 330-332 (2007).
237. Fountoulakis KN, Gonda X, Siamouli M, Rihmer Z. Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence. J. Affect. Disord. DOI: 10.1016/j.jad.2008.06.014 (2008) (Epub ahead of print).
238. Rucci P, Frank E, Kostelnik B et al. Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy. Am. J. Psychiatry 159(7), 1160-1164 (2002).
239. Bauer MS. An evidence-based review of psychosocial treatments for bipolar disorder. Psychopharmacol. Bull. 35(3), 109-134 (2001).
240. Sachs GS, Yan LJ, Swann AC, Allen MH. Integration of suicide prevention into outpatient management of bipolar disorder. J. Clin. Psychiatry 62 (Suppl. 25), 3-11 (2001).
241. Taylor SJ, Kingdom D, Jenkins R. How are nations trying to prevent suicide? An analysis of national suicide prevention strategies. Acta Psychiatr. Scand. 95(6), 457-463 (1997).
242. Grandin LD, Yan LJ, Gray SM, Jamison KR, Sachs GS. Suicide prevention: increasing education and awareness. J. Clin. Psychiatry 62 (Suppl. 25), 12-16 (2001).
243. Gray SM, Otto MW. Psychosocial approaches to suicide prevention: applications to patients with bipolar disorder. J. Clin. Psychiatry 62 (Suppl. 25), 56-64 (2001).
244. Pearson JL, Stanley B, King CA, Fisher CB. Intervention research with persons at high risk for suicidality: safety and ethical considerations. J. Clin. Psychiatry 62(Suppl. 25), 17-26 (2001).
245. Hawton K, McKeown S, Day A et al. Evaluation of out-patient counselling compared with general practitioner care following overdoses. Psychol. Med. 17(3), 751-761 (1987).
246. McLeavey BC, Daly RJ, Ludgate JW, Murray CM. Interpersonal problem-solving skills training in the treatment of self-poisoning patients. Suicide Life Threat. Behav. 24(4), 382-394 (1994).
247. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch. Gen. Psychiatry 50(12), 971-974 (1993).
248. Salkovskis PM, Atha C, Storer D. Cognitive-behavioural problem solving in the treatment of patients who repeatedly attempt suicide. A controlled trial. Br. J. Psychiatry 157, 871-876 (1990).
249. Egan MP. Contracting for safety: a concept analysis. Crisis 18(1), 17-23 (1997).
250. Marneros A, Rottig S, Wenzel A, Bloink R, Brieger P. Affective and schizoaffective mixed states. Eur. Arch. Psychiatry Clin. Neurosci. 254(2), 76-81 (2004).
251. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom. Med. 67(1), 1-8 (2005).
252. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 292(3), 338-343 (2004).
253. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch. Gen. Psychiatry 57(4), 311-317 (2000).
254. Roy A. Suicide. In: Kaplan and Sadock's Comprehensive Textbook of Psychiatry. Sadock BJ, Sadock VA (Eds). Lippincott Williams & Wilkins, PA, USA 2031-2040 (2000).
255. Rihmer Z. Suicide risk in mood disorders. Curr. Opin. Psychiatry 20(1), 17-22 (2007).
256. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J. Affect. Disord. 84(2-3), 233-242 (2005).
257. Coryell W, Andreasen NC, Endicott J, Keller M. The significance of past mania or hypomania in the course and outcome of major depression. Am. J. Psychiatry 144(3), 309-315 (1987).
258. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J. Affect. Disord. 26(2), 127-140 (1992).
259. Endicott J, Nee J, Andreasen N et al. Bipolar II. Combine or keep separate? J. Affect. Disord. 8(1), 17-28 (1985).
260. Vieta E, Benabarre A, Colom F et al. Suicidal behavior in bipolar I and bipolar II disorder. J. Nerv. Ment. Dis. 185(6), 407-409 (1997).
261. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J. Affect. Disord. 68(2-3), 167-181 (2002).
262. Rihmer Z, Szadoczky E, Furedi J, Kiss K, Papp Z. Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary. J. Affect. Disord. 67(1-3), 175-179 (2001).
263. Judd LL, Akiskal HS, Schettler PJ et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J. Affect. Disord. 73(1-2), 19-32 (2003).
264. Henry C, Van den Bulke D, Bellivier F et al. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J. Clin. Psychiatry 64(3), 331-335 (2003).
265. Sato T, Bottlender R, Schroter A, Moller HJ. Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. Acta Psychiatr. Scand. 107(4), 268-274 (2003).
266. Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am. J. Psychiatry 159(6), 909-916 (2002).
267. Rihmer Z, Barsi J, Veg K, Katona CL. Suicide rates in Hungary correlate negatively with reported rates of depression. J. Affect. Disord. 20(2), 87-91 (1990).
268. Rihmer Z, Rutz W, Barsi J. Suicide rate, prevalence of diagnosed depression and prevalence of working physicians in Hungary. Acta Psychiatr. Scand. 88(6), 391-394 (1993).
269. Tacchi MJ, Scott J. Improving Adherence in Schizophrenia and Bipolar Disorders. Wiley, Chichester, UK (2005).
270. Tatarelli R. Drugs and human interactions. Ann. Ist. Super Sanita 28(2), 197-202 (1992).
271. Noble LM. Doctor-patient communication and adherence to treatment. In: Adherence to Treatment in Medical Conditions. Myer LB, Midence K (Eds). Wiley, London, UK 51-82 (1998).
272. Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am. J. Psychiatry 153(8), 993-1000 (1996).
273. Weiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J. Clin. Psychiatry 59(4), 172-174 (1998).
274. Keck PE Jr, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 155(5), 646-652 (1998).
275. Strober M, Morrell W, Lampert C, Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am. J. Psychiatry 147(4), 457-461 (1990).
276. Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv. Rev. Psychiatry 1(3), 131-144 (1993).
277. Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J. Clin. Psychiatry 61(Suppl. 9), 97-104 (2000).
278. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J. Affect. Disord. 18(4), 259-266 (1990).
279. Jamison KR, Akiskal HS. Medication compliance in patients with bipolar disorder. Psychiatr. Clin. North Am. 6(1), 175-192 (1983).
280. Colom F, Vieta E, Martinez-Aran A et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J. Clin. Psychiatry 61(8), 549-555 (2000).
281. Baldessarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder: risks and management. CNS Spectr. 11(6), 465-471 (2006).
282. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19), 2511-2518 (1990).
283. Pompili M, Lester D, Girardi P, Tatarelli R. High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use. Subst. Abus. 28, 25-30 (2007).
284. Pompili M, Innamorati M, Raja M et al. Suicide risk in depression and bipolar disorder: do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent? Neuropsychiatr. Dis. Treat. 4, 247-255 (2008).
285. Galfalvy H, Oquendo MA, Carballo JJ et al. Clinical predictors of suicidal acts after major depression in bipolar disorder: a prospective study. Bipolar Disord. 8(5 Pt 2), 586-595 (2006).
286. Dumais A, Lesage AD, Alda M et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 162(11), 2116-2124 (2005).
287. Weissman M, Fox K, Klerman GL. Hostility and depression associated with suicide attempts. Am. J. Psychiatry 130(4), 450-455 (1973).
288. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry 156(2), 181-189 (1999).
289. Baca-Garcia E, Oquendo MA, Saiz-Ruiz J, Mann JJ, de Leon J. A pilot study on differences in aggression in New York City and Madrid, Spain, and their possible impact on suicidal behavior. J. Clin. Psychiatry 67(3), 375-380 (2006).
290. Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychosis and mania. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Brunton LL, Lazo JS, Parker KL (Eds). McGraw-Hill Press, NY, USA 461-500 (2005).
291. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, Chapter 17. Brunton LL, Lazo JS, Parker KL (Eds). McGraw-Hill Press, NY, USA 429-459 (2005).
292. Martinez C, Rietbrock S, Wise L et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 330(7488), 1-7 (2005).
293. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 330(7488), 385 (2005).
294. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am. J. Psychiatry 160(4), 790-792 (2003).
295. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant drug trials. Arch. Gen. Psychiatry 63(3), 246-248 (2006).
296. Pompili M, Tatarelli G, Rinaldi G, Lester D. Medical staff and suicide risk in schizophrenia. In: Suicide in Schizophrenia. Tatarelli R, Pompili M, Girardi P (Eds). Nova Science Publishers Inc., NY, USA 341-352 (2007).
297. Farberow NL, Shneidman ES, Neuringer C. Case history and hospitalization factors in suicides of neuropsychiatric hospital patients. J. Nerv. Ment. Dis. 142(1), 32-44 (1966).
298. Morgan HG, Priest P. Assessment of suicide risk in psychiatric in-patients. Br. J. Psychiatry 145, 467-469 (1984).
299. Morgan HG, Priest P. Suicide and other unexpected deaths among psychiatric in-patients. The Bristol confidential inquiry. Br. J. Psychiatry 158, 368-374 (1991).
300. Kullgren G. Factors associated with completed suicide in borderline personality disorder. J. Nerv. Ment. Dis. 176(1), 40-44 (1988).
301. Schwartz DA, Flinn DE, Slawson PF. Suicide in the psychiatric hospital. Am. J. Psychiatry 132(2), 150-153 (1975).
302. Shah AK, Bell P. Fluctuating suicidal ideation among psychogeriatric inpatients. Presented at: Workshop of the International Psychogeriatric Association. Reykjavik, Iceland, 4-5 October 1996.
303. Saarinen PI, Lehtonen J, Lonnqvist J. Suicide risk in schizophrenia: an analysis of 17 consecutive suicides. Schizophr. Bull. 25(3), 533-542 (1999).
304. Pompili M, Mancinelli I, Tatarelli R. Stigma as a cause of suicide. Br. J. Psychiatry 183, 173-174 (2003).
305. World Health Organization International suicide rates (2003) www.who.int/en/
306. Tondo L, Baldessarini RJ. Suicide: an overview. Medscape Internet Publications (2001) www.medscape.com/viewprogram/353
307. US Food and Drug Administration. Information for healthcare professionals suicidality and antiepileptic drugs (2008) www.fda.gov/cder/drug/infosheets/ hcp/antiepilepticshcp.htm